GADD45α-R-loop通路缺陷与糖尿病肾病肾损伤
该研究探讨GADD45α在糖尿病肾病中的作用机制。通过链脲佐菌素诱导的糖尿病小鼠模型及体外高糖处理的人肾近端小管上皮细胞,发现GADD45α表达降低与肾功能障碍相关,其敲除加重肾损伤而过表达减轻损伤。机制上GADD45α与STEAP4启动子上的R-loop相互作用,招募TET1激活STEAP4转录,通路缺陷加剧线粒体损伤、脂代谢紊乱和氧化应激。
要点
- 糖尿病肾病中GADD45α表达降低且与肾功能障碍相关
- GADD45α通过R-loop招募TET1激活STEAP4转录
- 靶向GADD45α-R-loop通路有望成为糖尿病肾病治疗策略
核心结论
- GADD45α缺陷通过干扰R-loop及抑制STEAP4启动子去甲基化加重糖尿病肾病。
- 靶向GADD45α-R-loop通路对糖尿病肾病具有治疗潜力。
研究设计与样本
- 采用链脲佐菌素腹腔注射建立糖尿病小鼠模型。
- 在野生型、GADD45α敲除及肾小管特异性GADD45α过表达小鼠中分析肾脏组织学和生化指标。
- 体外用GADD45α慢病毒过表达人肾近端小管上皮细胞(HK-2)并以高糖处理验证机制。
主要发现
- 糖尿病肾病肾脏中GADD45α表达降低并与肾功能障碍相关。
- GADD45α敲除加重肾损伤,而过表达减轻肾损伤。
- GADD45α与STEAP4启动子上的R-loop相互作用并招募TET1激活STEAP4转录。
- GADD45α-R-loop通路缺陷加剧线粒体损伤、脂代谢紊乱和氧化应激。
关键数值与推荐
- GADD45α通过启动子去甲基化增强STEAP4表达以维持肾脏健康。
- 糖尿病肾病中较低的GADD45α水平阻碍R-loop形成,减少STEAP4去甲基化和表达。
临床怎么用
- GADD45α-R-loop通路可作为糖尿病肾病创新治疗策略的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Growth arrest and DNA damage–inducible 45α (GADD45α) is crucial for maintaining kidney health by enhancing six-transmembrane epithelial antigen of the prostate 4 expression through promoter demethylation. In diabetic nephropathy, lower GADD45α levels hinder R-loop formation, leading to decreased six-transmembrane epithelial antigen of the prostate 4 demethylation and expression. Targeting the GADD45α-R-loop pathway holds promise for innovative diabetic nephropathy treatment strategies. BACKGROUND: Diabetic nephropathy is a primary cause of kidney failure. Persistent hyperglycemia causes metabolic perturbations epigenetically dysregulating gene expression in kidney cells, thereby leading to diabetic nephropathy pathogenesis. On analyzing the Gene Expression Omnibus database by using machine learning algorithms, our preliminary results demonstrated that growth arrest and DNA damage–inducible 45α (GADD45α) might serve as key regulators in diabetic nephropathy. Furthermore, emerging evidence has shown that R-loops, the three-stranded DNA–RNA structures, are crucial to gene expression during diabetic nephropathy. Therefore, this study aimed to investigate the role of GADD45α in diabetic nephropathy by modulating epigenetic alterations through interaction with R-loops. METHODS: A diabetic mouse model was established by injecting streptozotocin intraperitoneally into mice. Kidney histology and biochemical markers were analyzed in wild-type, GADD45α knockout, and renal tubule–specific GADD45α-overexpressing mice. The GADD45α lentivirus was used to induce the overexpression of GADD45α in human kidney-2 (a proximal tubular epithelial cell line) cells, while high-glucose treatment was applied to verify the mechanisms in vitro. RESULTS: GADD45α expression was reduced in kidneys of diabetic nephropathy, correlating with kidney dysfunction. GADD45α knockout worsened kidney injuries, while overexpression mitigated them. Mechanistically, GADD45α interacted with R-loops on the six-transmembrane epithelial antigen of the prostate 4 (STEAP4) promoter, recruiting ten eleven translocation 1 to activate STEAP4 transcription. Deficiency in the GADD45α-R-loop pathway exacerbated mitochondrial injury, disrupted lipid metabolism, and increased oxidative stress in diabetic nephropathy. CONCLUSIONS: Deficiency of GADD45α exacerbates diabetic nephropathy by interacting with R-loops and inhibiting STEAP4 promoter demethylation. Targeting the GADD45α-R-loop pathway offers therapeutic potential against diabetic nephropathy.
引用
- Li XQ, Zhang JX, Li L, et al. Deficiency of Growth Arrest and DNA Damage-Inducible 45 α -R-Loop Pathway and Kidney Injury in Diabetic Nephropathy. J Am Soc Nephrol. 2025. PMID: 40100277. doi:10.1681/ASN.0000000681
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。